Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. European Commission. European Cancer Information System [cited 2023 Jul 31]. https://ecis.jrc.ec.europa.eu/.
2. International Agency for Research on Cancer. Cancer Tomorrow [cited 2023 Jul 31]. https://gco.iarc.fr/tomorrow/en.
3. Polkowska M, Ekk-Cierniakowski P, Czepielewska E, Wysoczański W, Matusewicz W, Kozłowska-Wojciechowska M. Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data. J Cancer Res Clin Oncol. 2017;143:2087–94.
4. Assié J-B, Corre R, Levra MG, Calvet CY, Gaudin A-F, Grumberg V, et al. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study). Ther Adv Med Oncol. 2020;12:1758835920967237.
5. Newton M, Stoddart K, Travaglio M, Troein P. EFPIA Patients W.A.I.T. Indicator 2022 Survey.